Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated drug compounds where the bromo and carboxylic acid functional groups allow for further chemical modifications. Its structure supports the creation of active pharmaceutical ingredients (APIs) with enhanced metabolic stability and binding affinity. Commonly employed in cross-coupling reactions such as Suzuki or Heck reactions to build complex aromatic systems in medicinal chemistry. Also utilized in agrochemical research for designing bioactive molecules with improved environmental stability.